Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects.

about

Physiologically Based Pharmacokinetic Approach to Determine Dosing on Extracorporeal Life Support: Fluconazole in Children on ECMO

P2860

Q58783779-E00BC1DC-DA8D-4FB0-8687-DDDADD8B993E

P2860

Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects.

Item

http://www.wikidata.org/entity/Q38639379

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Improving Pediatric Protein Bi ...... Healthy and Infected Subjects.

@en

type

Item

label

Improving Pediatric Protein Bi ...... Healthy and Infected Subjects.

@en

prefLabel

Improving Pediatric Protein Bi ...... Healthy and Infected Subjects.

@en

P1476

Improving Pediatric Protein Bi ...... Healthy and Infected Subjects

@en

P2093

Andrea N Edginton

http://www.w3.org/2001/XMLSchema#string

Anil R Maharaj

http://www.w3.org/2001/XMLSchema#string

Christoph P Hornik

http://www.w3.org/2001/XMLSchema#string

Michael Cohen-Wolkowiez

http://www.w3.org/2001/XMLSchema#string

P2860

Predicting plasma concentrations of bisphenol A in children younger than 2 years of age after typical feeding schedules, using a physiologically based toxicokinetic model

The 1.8-A crystal structure of alpha1-acid glycoprotein (Orosomucoid) solved by UV RIP reveals the broad drug-binding activity of this human plasma lipocalin

Neonatal serum protein levels as indicators of nutritional status: normal values and correlation with anthropometric data.

Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents

Laser immunonephelometry reference intervals for eight serum proteins in healthy children.

Prediction of the clearance of eleven drugs and associated variability in neonates, infants and children.

Alpha-1-acid glycoprotein.

Changes in plasma protein binding have little clinical relevance.

Evidence for differences in the binding of drugs to the two main genetic variants of human alpha 1-acid glycoprotein

Protein binding of propranolol and verapamil enantiomers in maternal and foetal serum

P2888

s40262-017-0576-7

P304

577-589

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40262-017-0576-7

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Daniel Gonzalez

P577

2018-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090993795

http://www.w3.org/2001/XMLSchema#string

P698

28779462

http://www.w3.org/2001/XMLSchema#string

P932

5797516

http://www.w3.org/2001/XMLSchema#string

Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects.

about

P2860

P2860

Improving Pediatric Protein Binding Estimates: An Evaluation of α1-Acid Glycoprotein Maturation in Healthy and Infected Subjects.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932